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Suosuo grape (the fruits of Vitis vinifera L) has been used for prevention and treatment of liver diseases in Uighur folk medicine
in China besides its edible value. In this study, the hepatoprotective eﬀects of total triterpenoids (VTT) and total ﬂavonoids (VTF)
from Suosuo grape were evaluated in Bacille-Calmette-Guerin- (BCG-) plus-lipopolysaccharide- (LPS-) induced immunological
liver injury (ILI) in mice. Various dose groups (50, 150, and 300mg/kg) of VTT and VTF alleviated the degree of liver injury
of ILI mice, eﬀectively reduced the BCG/LPS-induced elevated liver index and spleen index, hepatic nitric oxide (NO), and
malondialdehyde (MDA) content, increased liver homogenate alanine aminotransferase (ALT) and aspartate aminotransferase
(AST) levels, and restored hepatic superoxide dismutase (SOD) activity in ILI mice. VTT and VTF also signiﬁcantly inhibited
intrahepatic expression of Th1 cytokines (IFN-γ and IL-2) in ILI mice and increased intrahepatic expression of Th2 cytokines (IL-
4 and IL-10). Moreover, the increased Bax/Bcl-2 ratio was signiﬁcantly downregulated by VTT and VTF in liver tissue of ILI mice.
These results are comparable to those of biphenyl dicarboxylate (DDB, the reference hepatoprotective agent) and suggest that VTT
and VTF play a protective role against immunological liver injury, which may have important implications for our understanding
of the immunoregulatory mechanisms of this plant.
1.Introduction
Chronic hepatitis B (CHB) remains a major public health
problem, despite the available eﬀective vaccines. There are
about 400 million people with hepatitis B virus (HBV) infec-
tion, who are at high risk of developing cirrhosis and/or pri-
maryhepatocellularcarcinoma.Upto30%ofthechroniccar-
riers will die of complications of these chronic liver diseases
[1]. According to the HBV replication cycle and the host
immune response, two major strategies can be applied to
treat HBV infection: (i) regulation of the immune function
with immunomodulatory agents such as alpha-interferon
and pegylated interferon; (ii) inhibition of the viral replica-
tion at various stages including inhibition of HBV entry into
the hepatocyte by interfering virus-cell interaction, inhibi-
tion of viral transcription and synthesis of viral proteins, or
inhibition of HBV DNA polymerase activity [2–4].
Grape(thefruitofVitis vinifera L.)isafavoritefood wide-
ly distributed to the world and also has been used to treat
various diseases because of many biological activities in tra-
ditional medicine, such as diarrhea, hepatitis, and stomach-
aches [5]. Suosuo grape is a breed of Grape and mainly pro-
duced in Turpan, Shanshan, and Hetian regions of Xinjiang
in China and has been used as a folk medicine for hepatitis
and pedo-measles [6].
The active compounds of Grape include triterpenoids,
ﬂavonoids, and polysaccharides [7–9], and these compounds
have been suggested to be responsible for the pharmaco-
logical activities observed with grape [10]. Previous studies
showed that total triterpenoids (VTT), total ﬂavonoids
(VTF), and polysaccharides (VTP) from Suosuo grape could
eﬀectively suppress the secretion of HBsAg and HBeAg
from HepG2.2.15 cells in a dose-dependent manner, as well2 Evidence-Based Complementary and Alternative Medicine
as the HBV DNA, and the results of orthogonal design
experiment showed that the combination of extracts (VTT
20μg/mL, VTF 50μg/mL and VTP 50μg/mL) had the
best optimistic inhibitory eﬀect on HBeAg secretion [11].
In addition, VTT had signiﬁcant protective eﬀects against
immunological liver damage induced by Bacille Calmette-
Guerin (BCG) plus lipopolysaccharide (LPS) in vitro [12].
Although anti-HBV and hepatoprotective activities of
extracts from Suosuo grape have been veriﬁed by in vitro
experiments, an in vivo study has not been published so far.
Therefore, in this study, we aimed to further investigate the
possible immunological mechanism of the hepatoprotective
activity of VTT and VTF from Suosuo grape by BCG-plus-
LPS-induced mice immunological liver damage.
2.MaterialsandMethods
2.1. Plant Material. Suosuo grape were collected from
Tulufan, Xinjiang Uirghur autonomous region, in China, in
May 2006. The plant materials were identiﬁed as Suosuo
grape by Researcher Yan Fu Zhang, Institute of Materia
MedicaofXinjiang.Avoucherspecimenwasdepositedatthe
Institute of Materia Medica of Xinjiang in China.
2.2. Chemicals. LPS (E. coli 0555:B5) was a product from
Sigma(St.Louis,MO,USA).BCGvaccinewasobtainedfrom
theShanghaiInstituteofBiologicalProducts.Biphenyldicar-
boxylate (DDB, content more than 99% as determined by
HPLC) was bought from Dezhou Deyao Pharmaceutical Co
(Shandong,China).Assaykitsforaspartateaminotransferase
(AST) and alanine aminotransferase (ALT) were provided
by Zhongsheng Tech (Beijing, China). Commercial kits used
for determining lipid peroxidation, nitric oxide (NO), and
superoxide dismutase (SOD) activity were obtained from
the Jiancheng Institute of Biotechnology (Nanjing, China).
Rat anti-mouse CD8-FITC and CD4-FITC monoclonal
antibodies were from Caltag Co (Burlingame, CA, USA).
MurineELISAkitsforIFN-γ,IL-2,IL-4,andIL-10werefrom
Biosource Co (Camarillo, CA, USA). Bax and Bcl-2 with
mouse monoclonal antibodies were from Biosyn. Biotech.
Co. (Beijing, China). All other chemicals were of analytical
grade and commercially available.
2.3. Animals. The experiments were conducted on male
Kunming strain mice (Experimental Animal Center of
Xinjiang Medical University) weighing 20 ± 2g. Animals
werehousedinplasticcageswitharoomtemperatureof22 ±
1◦C under a 12h light-dark cycle and provided with rodent
chow and water ad libitum. The studies were carried out in
accordance with the current recommendations as described
by the ethical guidelines for investigation and were approved
by the Ethical Committee of Xinjiang Medical University
(SYXK [Xin] 2003-0001).
2.4. Preparation of VTT and VTF. Five kilograms of Suosuo
grape was extracted with deionized water under reﬂux at
80◦C for 6h in several batches. The combined water extracts
were evaporated under vacuum to speciﬁc gravity of 1.1-
1.2, and ethanol about ﬁve times the original volume was
added and kept at 4◦C for 24h to obtain precipitates. The
gruﬀs were extracted with 95% ethanol under reﬂux at
80◦C for 6h in several batches. The extracts were combined,
ﬁltered, and evaporated under vacuum. The concentrated
extracts were diluted with water and successively treated
with petrol ether and EtOAc. Total triterpenoids (VTT) was
prepared by the method of 95% ethanol recrystallized from
the EtOAc fraction. The mother liquor of VTT crystalline
powder combined with supernatant of ethanol precipitation
to be separated by AB-8 resin. After deionized water eluting
and cleaning impurities, 50% ethanol eluent was collected to
aﬀord total ﬂavonoids (VTF).
2.5. Quantiﬁcation and Standardization of VTT and VTF.
Chromatographic separation was achieved by using HPLC
system consisting of a Shimadzu LC-10AD and YMC-
Pack ODS-A column (150 × 4.6mm, 5μm, with pre-
column); the mobile phase consisted of methanol and
H2O (86:14). Detection wavelength was 215nm. The ﬂow
rate was 1.0mL/min. Oleanolic acid content of VTT was
65.52mg/100mg. Total ﬂavonoids content in the extracts
was determined using described methods in Chinese phar-
macopeia. Quantitation was based on the standard curve of
rutin (0.2–1.0mg/mL),dissolved in 95% ethanol.Flavonoids
content was calculated with rutin as the standard and total
ﬂavonoids content of VTF was 35.28mg/100mg.
2.6. Isolation and Identiﬁcation of the Compounds. The VTT
fraction was subjected to silica gel column chromatog-
raphy and eluted with a gradient of Petrol ether/EtOAc,
resulting in the isolation of oleanolic acid (1)[ 13], as
a white powder, m.p. 291-292◦C, from fraction eluted
with Petrol ether/EtOAc (90:10, v/v). The chromatographic
fractionation on AB-8 resin of the VTF fraction aﬀorded
a crude ﬂavonoid from EtOH/H2O (50:50, v/v) eluate
that was further puriﬁed by Sephadex LH-20 using MeOH
as eluent repeatedly, yielding 130mg of isoquercitrin (2)
[14], as a yellow needle crystals, m.p. 232–234◦C, 97mg of
quercitrin 3-O-β-D-glucuronate sodium (3)[ 15], as yellow
powder, m.p. 198.5–201.3◦C, 13mg of quercitrin 3-O-β-D-
glucuronopyranoside ethyl ester (4)[ 16], as yellow powder,
m.p. 215–218◦C ,7 m go fg a l l i ca c i d( 5)[ 17], as colorless
needle crystals, m.p. 236–238◦C ,a n d1 1m go fc a f t a r i ca c i d
(6)[ 18], as white powder, m.p. 123–125◦C. The structures of
the compounds were identiﬁed by their spectroscopic data
(MS, 1H NMR, and 13C NMR), comparison with spectral
dataobtainedfromtheliterature,andco-TLCwithauthentic
samples (Figure 1).
2.7. Experimental Procedure in Mice. Mice were randomly
dividedintoninegroups(n = 12pergroup).Immunological
liver injury was induced via injection of a small dose of
LPS into BCG-pretreated mice, as previously reported [19].
Brieﬂy, 1mg of BCG in 0.2mL saline (approximately 5 ×107
viable units per mouse) was injected via the lateral tail vein,
with the exception of the control group, who received saline
alone. VTT, VTF, and DDB were suspended in 0.5% sodium
carboxymethylcellulose (CMC-Na) solution for administra-
tion. In the treatment groups, DDB (200mg/kg·BW, asEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Chemical structure of compounds.
a reference drug), VTT (50, 150, or 300mg/kg·BW), or VTF
(50, 150 or 300mg/kg·BW) was given daily via gavage for
ap e r i o do f1 2d a y s .T h en o r m a lg r o u pw a sg i v e na ne q u a l
volumeofwater.Twelvedayslater,allofthetreatedmicewere
given 10μg of LPS in 0.2mL saline (control mice received
saline alone) via lateral tail vein injection. Sixteen hours
followingLPSinjection,bloodsampleswerecollectedinglass
tubes from orbital sinus for the analysis of CD4+/CD8+
and Th1 (IFN-γ, IL-2)/Th2 (IL-4, IL-10). Afterwards, all
the animals were sacriﬁced by decapitation and livers and
spleens were quickly excised freed from any adhering tissues
and weighed. The liver and spleen weights of the mice/the
wet weights (mg) per 10g mouse × 100% were taken as
the liver index (liver/body weight ratio), and spleen index
(spleen/body weight ratio), respectively. Furthermore, some
liver tissues were washed and perfused with chilled normal
saline,mincedandhomogenizedinanicebathusingaDY89-
1-homogenizer (Ningbo Scientz Biotechnology Co, China,
3000rpm for 10min) in chilled normal saline to obtain 10%
liver homogenate for the estimation of AST, ALT, NO, MDA,
and SOD. Other liver tissues were placed in neutralized
formalin before being stained and analyzed for pathological
changes and the expression of bax/bcl-2.
2.8. Measurement of Liver Homogenate Contents of ALT, AST,
SOD, MDA, and NO. Livers were homogenized, and the
activities of AST and ALT and the MDA contents were
determined using commercial kits. AST and ALT activities
were determined as described previously [20] and expressed
as an international unit per liter (U/L). MDA in liver tissue
was determined by the thiobarbituric acid method [21].
Assays for total SOD activity were based on its ability to
inhibit the oxidation of oxyamine by the xanthine-xanthine
oxidase system [22] .T h el e v e l so fN Oi nl i v e rh o m o g e n a t e
were assayed using the Griess reagent [23].
2.9. Quantiﬁcation of Cytokine Concentrations in Plasma
Samples. The concentrations of IFN-γ and IL-2, IL-4, and
IL-10 in plasma samples were determined with speciﬁc
ELISAs according to kit introduction.
2.10. Flow Cytometry. Liver lymphocytes were washed twice
with Dulbecco’s-PBS at pH 7.2 (Sigma) and once with
RPMI 1640 medium (Sigma). Erythrocytes were lysed in
0.84% NH4Cl. Pure lymphocytes were resuspended at a ﬁnal
concentration of 1 × 106 cells per 1mL. After incubation
at 4◦C for 30 minutes, the cells were directly treated
with rat anti-mouse CD4+-FITC- and CD8+-FITC-labeled
monoclonal antibodies at 4μLp e rt u b e .C e l ls a m p l e sw e r e
washed three times in 0.1% sodium azide-PBS and analyzed
by ﬂow cytometry. Data for 10000 cells, falling within FSC
and SSC gates set for lymphocytes, were collected from each
sample with a FACScan ﬂow cytometer (Becton Dickinson
Biosciences). All data ﬁles were analyzed with Cell Quest
software.
2.11. Histological Examination. The liver tissue was collected
and immediately ﬁxed in 10% formalin, dehydrated in a
graded ethanol (50–100%) series, cleared in xylene, and
embedded in paraﬃn. Sections (4-5μm) were prepared and
stained with hematoxylin and eosin (HE) dyes for photomi-
croscopic observations. For histological evaluation of the
liver injury, areas of necrotic lesions were microscopically
evaluated using an MCID Image analyzer. The degree of
liver damage was categorized into ﬁve groups: Grade 0,
no necrosis; Grade 1, spotty necroses around liver lobular4 Evidence-Based Complementary and Alternative Medicine
Table 1: Eﬀects of VTT and VTF on liver index, spleen index, and homogenate ALT and AST activities in ILI mice.
Group n Dose (mg/kg) ALT (U/g prot) AST (U/g prot) Liver index (%) Spleen index (%)
Normal 12 631.78 ±81.08 215.73 ±26.19 0.5564 ±0.0577 0.0298 ±0.0083
BCG + LPS 10 242.75 ±63.15a 51.59 ±12.03a 0.6979±0.1238a 0.0843 ±0.0247a
BCG + LPS + DDB 12 200 519.57±154.05b 90.61 ±13.30b 0.5466±0.0628b 0.0502 ±0.0101b
BCG + LPS + VTT 11 50 366.56 ±83.77b 66.74 ±18.56 0.5810±0.0655b 0.0619 ±0.0171b
11 150 499.62 ±96.11b 81.86 ±14.86b 0.5801±0.0725b 0.0646 ±0.0116b
12 300 507.19±138.13b 96.69 ±33.88b 0.5871±0.0556b 0.0585 ±0.0160b
BCG + LPS + VTF 10 50 408.70 ±57.85b 63.63 ±22.47 0.5524±0.0908b 0.0581 ±0.0213b
12 150 489.24±130.33b 79.97 ±11.54b 0.5457±0.0557b 0.0539 ±0.0113b
12 300 502.85±129.12b 85.60 ±18.40b 0.6090±0.0643b 0.0552 ±0.0092b
Values are the mean ± S.D. aP<0.01, compared with normal group; bP<0.01, compared with ILI model group.
central vein, interspersed inﬂammatory cell inﬁltration, and
thermophilic acid body formation; Grade 2, necrotic area<
33.3%; Grade 3, necrotic area > 33.3% and < 66.7%;
Grade 4, necrotic area > 66.7% [24]. The slides were
scored independently by two pathologists who had no prior
knowledge of their source. Each sample was observed at 100x
magniﬁcation. The degree of liver damage was expressed as
the mean of 8 diﬀerent ﬁelds of view on each slide.
2.12. Assay for the Expression of Bcl-2 and Bax. Represen-
tative paraﬃn blocks were serially cut at 5μm thickness,
deparaﬃnized in xylene, rehydrated in a graded ethanol
series, and washed for 5min with phosphate-buﬀered saline.
For antigen retrieval, the sections were immersed in 10mM
citrate buﬀer (pH 6.0) and boiled. Endogenous peroxidase
was blocked by incubation of the slides for 30min with
3% hydrogen peroxide in methanol. Sections were then
incubated for 24h at 4◦C with primary mouse monoclonal
antibodies Bcl-2 (at 1:100 dilution) and Bax (at 1:100
dilution) at room temperature, respectively. The slides were
tinctured with DAB and mounted according to SABC kits.
A brown reaction indicated positive expression of Bcl-2 and
Bax. The integral optical density (IOD) of Bcl-2 and Bax
positive cells was determined.
2.13. Statistical Analysis. A l lv a l u e sa r ep r e s e n t e da sm e a n±
S.D. Statistical analysis of the data for multiple comparisons
was performed by one-way analysis of variance (ANOVA)
followed by Duncan’s test (SPSS 12.0 software package). For
a single comparison, the signiﬁcance of diﬀerences between
means was determined by the t-test. A level of P<0.05 was
accepted as statistically signiﬁcant.
3. Results
3.1. Protective Eﬀects of VTT and VTF on BCG-Plus-LPS-
Induced ILI in Mice. The liver index and spleen index were
signiﬁcantly increased in ILI mice. Table 1 showed that
the elevated liver index and spleen index were markedly
reduced by daily VTT and VTF treatment with various
doses (P<0.01), and the reduction of liver homogenate
ALT and AST levels was also signiﬁcantly increased by daily
VTT and VTF treatment with various doses (P<0.01).
Liver histopathologic examination showed no histological
abnormalities in normal mice (Figure 2(a)). Liver cell wide-
range laminated necrosis, acidophilia changes, and portal
inﬁltration by inﬂammatory cells were seen after LPS injec-
tion in the BCG-primed mice (Figure 2(b)). The area, extent
of necrosis, and degree of inﬁltration by inﬂammatory cells
were substantially ameliorated by DDB (200mg/kg), VTT
(50, 150, or 300mg/kg), and VTF (50, 150, or 300mg/kg)
treatments (P<0.05) (Figures 2(c), 2(d), 2(e), 2(f), 2(g),
2(h),a n d2(i) and Table 2).
3.2.EﬀectofVTTandVTFonLiverHomogenateSODActivity,
MDA and NO Content in ILI Mice. Liver homogenate MDA
content in ILI mice was signiﬁcantly higher than that of
the normal group, while total liver SOD activity was lower.
After treatment with VTT and VTF at diﬀerent doses (50,
150, or 300mg/kg), liver homogenate SOD activity was
restored signiﬁcantly and MAD content was attenuated
signiﬁcantly. VTT and VTF (50, 150, or 300mg/kg) also
signiﬁcantly inhibited the increased production of NO in
liver homogenates of ILI mice (Table 3). The activities of
middle-dose group of the two extracts (150mg/kg) were
comparable to those of DDB (200mg/kg).
3.3. Inﬂuence of VTT and VTF on CD4+/CD8+ Cells in
ILI Mice. Flow cytometric analysis showed no statistically
signiﬁcant diﬀerences in percentages of CD4+ and CD8+
cells, either among the groups or within the same group
(P>0.05) (Figure 3).
3.4. Inﬂuence of VTT and VTF on Th1/Th2 Cytokine Release
in ILI Mice. The eﬀects of VTT, VTF, and DDB on LPS-
induced production of Th1/Th2 cytokines in plasma of
ILI mice are shown in Table 4. In the ILI mice, the levels
of Th1 cytokines IFN-γ and IL-2 were higher, while Th2
cytokinesIL-4andIL-10levelswerelowerthaninthenormal
group. After treatment with VTT and VTF (50, 150, or
300mg/kg), middle- and high-dose group of both extracts
can signiﬁcantly inhibit production of IFN-γ and IL-2 and
signiﬁcantly increased levels of IL-4 and IL-10 (P<0.01);
especially the eﬀect of high-dose group is comparable to that
of DDB (200mg/kg). In contrast, in the low-dose group, the
eﬀect on the ratio Th1/Th2 cytokines was weak.Evidence-Based Complementary and Alternative Medicine 5
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 2: Histological image of liver tissues from ILI mice indicating the hepatoprotective eﬀects of VTT and VTF. (a) Liver histopathologic
examination showed no histological abnormalities in normal mice. (b) The liver tissue of ILI model mice, showing wide-range laminated
necrosis, acidophilia changes, and portal inﬁltration. Signiﬁcant hepatoprotective eﬀects are seen in tissues primed with BCG and treated
with (c) DDB (200mg/kg), VTT at (d) 50, (e) 150, or (f) 300 mg/kg, or VTF at (g) 50, (H) 150, or (i) 300mg/kg followed by LPS challenge.
The degree of tissue damage was signiﬁcantly reduced. The tissues were surgically excised and subjected to histological study by staining with
hematoxylin and eosin. All the magniﬁcations are ×100.
Table 2: Eﬀects of VTT and VTF on the pathological grading changes in ILI mice.
Group Dose (mg/kg)
Degree of liver injury
P value
0 I II III IV
Normal 8 0 0 0 0
B C G + L P S 0 0017#
BCG + LPS + DDB 200 0 6 2 0 0 ∗
B C G + L P S + V T T 5 0 0 1322
150 1 4 2 1 0 ∗
300 1 3 3 1 0 ∗
B C G + L P S + V T F 5 0 1 1132∗
150 1 2 2 0 2 ∗
300 1 2 4 1 0 ∗
Each group consists of 8 mice, and ﬁgures represent number of mice per grade. #P<0.01, compared with normal group; ∗P<0.01, compared with ILI model
group.6 Evidence-Based Complementary and Alternative Medicine
Table 3: Eﬀect of VTT and VTF on liver homogenate SOD activities, MDA and NO content in ILI mice.
Group n Dose (mg/kg) SOD (U/mg prot) MDA (nmol/mg prot) NO (nmol/mg prot)
Normal 12 106.85 ±14.25 14.71 ±3.99 1.91 ±0.30
BCG + LPS 10 57.67 ±9.08a 32.49 ±6.22a 4.27 ±0.64a
BCG + LPS + DDB 12 200 92.84 ±14.55b 20.45 ±3.03b 2.26 ±0.54b
BCG + LPS + VTT 11 50 76.02 ±12.28b 25.52 ±7.78b 3.41 ±0.52b
11 150 85.59 ±12.07b 24.44 ±2.39b 2.82 ±0.56bc
12 300 87.49 ±11.98b 21.28 ±4.86b 2.37 ±0.40bc
BCG + LPS + VTF 10 50 62.91 ±12.34 24.08 ±4.87b 3.35 ±0.68b
12 150 93.14 ±29.34bc 22.13 ±2.26b 2.59 ±0.44bc
12 300 86.26 ±10.83bc 20.76 ±3.99b 2.34 ±0.47bc
Values are the mean ± S.D. aP<0.01, compared with normal group; bP<0.01, compared with ILI model group. cP<0.01, compared with low-dose group.
Table 4: Inﬂuence of VTT and VTF on Th1/Th2 cytokine release in ILI mice.
Group n Dose (mg/kg)
Th1 Th2
IL-2 (pg/mL) IFN-γ (pg/mL) IL-4 (pg/mL) IL-10 (pg/mL)
Normal 12 29.77 ±21.21 52.29 ±23.31 19.91 ±7.14 103.35 ±23.43
BCG + LPS 10 61.10 ±23.75a 116.13 ±22.40a 11.75 ±7.42b 47.11 ±28.84a
BCG + LPS + DDB 12 200 32.48 ±20.74c 68.00 ±26.72c 17.17 ±8.52 92.38±14.51c
BCG + LPS + VTT 11 50 63.59 ±27.34 108.31 ±33.16 12.20 ±9.14 54.05 ±20.43
11 150 54.87 ±20.85 94.01 ±32.32 14.78 ±8.87 67.77 ±21.59d
12 300 45.60 ±26.79 72.50 ±29.59c 15.55 ±5.99 80.33 ±21.71c
BCG + L PS + VTF 10 50 57.24 ±28.74 104.44 ±38.52 14.42 ±6.64 57.73 ±19.63
12 150 43.95 ±22.40 90.95 ±29.24 15.47 ±6.71 81.94 ±19.04c
12 300 36.78 ±18.59d 78.43 ±26.84d 15.78 ±7.39 84.66 ±23.64c
Values are the mean ± S.D. aP<0.01, bP<0.05, compared with normal group; cP<0.01, dP<0.01, compared with ILI model group.
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Figure 3: Eﬀects of VTT and VTF on diﬀerentiation of T cells in
ILI mice. The percentage of CD4+ and CD8+ cells in ILI cells was
detected by ﬂow cytometric assay using CD4 or CD8 monoclonal
antibody conjugated with FITC (A). DDB, BCG + LPS + DDB
(200μg/mL); VTT-L, BCG + LPS + VTT (50mg/kg); VTT-M, BCG
+LPS+VTT(150mg/kg);VTT-H,BCG+LPS+VTT(300mg/kg);
VTF-L, BCG + LPS + VTF (50mg/kg); VTF-M, BCG + LPS + VTF
(150mg/kg); VTF-H, BCG + LPS + VTF (300mg/kg). P>0.05
compared with normal group; P>0.05 compared with model
group.
3.5. Inﬂuence of VTT and VTF on the Expression of Bax/Bcl-2
Proteins in ILI Mice. In the livers of ILI mice, the expression
of Bax was increased in a dose-dependent manner compared
to normal, and the expression of Bcl-2 was decreased in
a dose-dependent manner compared to normal. The ratio
of Bax/Bcl-2 in the livers of immunological hepatic injured
mice was 1.89, which was higher than that of normal mice
(0.35). The inﬂuence of VTF on Bcl-2 was more evident than
thatofBax.TreatmentwithVTF,atallthreedoses,resultedin
asigniﬁcantincreaseintheexpressionofBcl-2anddecreased
the ratio of Bax/Bcl-2 to 0.78, 0.72, and 0.60, for VTF at 50,
150, or 300mg/kg, respectively, of which the eﬀect of high-
dose group was near to DDB (200mg/kg) (Figure 4). The
eﬀectofVTTwassimilartoVTFexceptthathigh-dosegroup
was a little weak as follows: 0.76, 0.74, and 0.73, for VTT at
50, 150, or 300mg/kg.
4. Discussion
The chemical analyses showed that VTT was rich in triter-
penoids compounds and the content of oleanolic acid was
65.52%; VTF was rich in ﬂavones compounds, and the
content of total ﬂavonoids was 35.28%. Both were mainly
characteristic constituents from Vitis vinifera L, of which
oleanolic acid is usually used as hepatoprotective drug. As a
breed of Vitis vinifera L, Suosuo grape is used to treat various
hepatitis in Uighur medicine, and its folk application was
veriﬁed though the eﬀect and mechanism of VTT and VTF
on immunological liver injury mice in this study.Evidence-Based Complementary and Alternative Medicine 7
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Figure 4:InﬂuenceofVTTandVTFontheexpressionofBax/Bcl-2
proteinsinILImice(n = 8).DDB,BCG+LPS+DDB(200μg/mL);
VTT-L, BCG + LPS + VTT (50mg/kg); VTT-M, BCG + LPS + VTT
(150mg/kg); VTT-H,BCG+LPS +VTT(300mg/kg); VTF-L,BCG
+ LPS + VTF (50mg/kg); VTF-M, BCG +LPS + VTF (150mg/kg);
VTF-H, BCG + LPS + VTF (300mg/kg). aP<0.01 compared with
normal group; bP<0.01 compared with ILI model group.
The model of immunological liver injury induced by
BCG plus LPS is similar to the pathological course of chronic
hepatic diseases in humans. In our study, the decrease of
AST and ALT and the increase of MDA and NO levels
in liver homogenates of ILI mice suggests enhanced lipid
peroxidation leading to tissue damage and failure of antiox-
idant defense mechanisms. Treatment with VTT, VTF, and
DDB (as a reference drug) during 12 days signiﬁcantly
prevented these changes. Moreover, VTT and VTF also sig-
nificantly increased SOD contents of the liver homogenate.
Hence, the mechanism of hepatoprotection of Vitis vinifera
L may be due to its antioxidant eﬀect. Histopathological
studies showed that LPS/BCG caused fatty degeneration and
necrosis of the liver tissue. Pretreatment with VTT and
VTF exhibited protection, which conﬁrmed the results of
biochemical studies. These results indicate that treatment
with VTT and VTF can protect the liver against LPS/BCG-
induced hepatotoxicity.
Th1-type cytokines tend to produce the proinﬂamma-
tory responses responsible for perpetuating autoimmune
responses. Excessive proinﬂammatory responses can induce
activation of CD8+ T lymphocytes (CTL), Kupﬀer cells, and
hepatic macrophages. Activated CTL may aggravate hepato-
cyteapoptosis,whileactivatedKupﬀercellsandmacrophages
can provoke massive liver necrosis through microcirculatory
disturbances, due to endothelial cell destruction and ﬁbrin
deposition in the hepatic sinusoids [25, 26]. The Th2-type
cytokines include IL-4 and IL-10, which has more of an
anti-inﬂammatory response. Th1 immunity is attenuated by
the Th2 immune reaction [27]. The optimal scenario would
therefore seem to be that humans should produce a well-
balanced Th1 and Th2 response, suited to the immune chal-
lenge. Therefore, liver necrosis can develop as a consequence
of any imbalance between Th1 and Th2 immune reactions
in the liver [28]. In ILI mice, the signiﬁcant immune balance
disorders were showed as increase of Th1 cytokines (IFN-γ
and IL-2) and decrease of Th2 cytokines (IL-4 and IL-10).
150 or 300mg/kg dose group of VTT and VTF may have
signiﬁcantly inhibited intrahepatic expression of Th1 cytok-
ines (IFN-γ and IL-2) and increased intrahepatic expression
of Th2 cytokines (IL-4 and IL-10). Thus, both extracts from
Suosuo grape could apparently produce a protective and
ameliorating eﬀect against liver tissue damage by regulating
cytokines and restoring Th1/Th2 balance though could not
promote proliferation and diﬀerentiation of immunological
cells.
Apoptosis is an essential physiological process that plays
ac r i t i c a lr o l ei nd e v e l o p m e n ta n dt i s s u eh o m e o s t a s i si nm u l -
ticellular organisms [29]. This study was to detect apoptotic
cells in the liver tissues with the expression of Bcl-2 and Bax
as proteins which are known to regulate this vital process.
Bcl-2 itself functions as a repressor of apoptosis whereas
another member of the family, bax, acts as a promoter of
cell death. Abnormal apoptosis of hepatocytes is part of
the pathological mechanism of acute or chronic hepatic
injury. As such, investigation of the eﬀects and mechanisms
of liver-protecting drugs on apoptotic events is of obvious
signiﬁcance to liver injury research [30, 31]. The ratio of
Bax/Bcl-2maymodulateornormalizetheoccurrenceofapop-
tosis. Both a reduction in Bax expression and an increase in
Bcl-2 expression were observed in Figure 4.V T Ta n dV T F
could be inhibiting the expression of Bax or promoting the
expression of Bcl-2, or both, with the end result being a
decrease in the Bax/Bcl-2 ratio in a dose-dependent manner.
In conclusion, the hepatoprotective eﬀect of extracts
from Vitis vinifera L (VTT and VTF) is related to its an-
tioxidative, immunoregulatory properties and its ability to
regulate hepatic apoptosis. The synergistic hepatoprotective
eﬀe c to fV TT ,V T F ,o ro t h e rc o m p o u n d sf r o mVitis vinifera L
will be subject to further study.
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